logo
Select company
Select metric
21.57%Cash to Assets Ratio
VS
Market
76
Sector
49
Industry
36
History
13
$ 0.7Close
$ 0.18 - $ 1.57 52-Week Range
Ticker Information

Ticker

PSTV

Company Name

PLUS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PLUS THERAPEUTICS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PSTV - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 10.35M$ 2.23M21.57%
3/31/2025$ 12.06M$ 9.87M81.84%
12/31/2024$ 6.63M$ 76K1.15%
9/30/2024$ 6.98M$ 1.22M17.53%
6/30/2024$ 11.21M$ 4.91M43.81%
3/31/2024$ 5.62M$ 2.9M51.61%
12/31/2023$ 11.39M$ 8.55M75.11%
9/30/2023$ 13.28M$ 11.01M82.89%
6/30/2023$ 14.2M$ 10.89M76.74%
3/31/2023$ 15.64M$ 12.72M81.36%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PLUS THERAPEUTICS INC's latest trailing twelve months (TTM) Cash to Assets stands at 65.44%.
  • Over the past 5 years, PLUS THERAPEUTICS INC's average Cash to Assets has been 66.71%.
  • The median Cash to Assets for PLUS THERAPEUTICS INC during this period was 77.77%
  • PLUS THERAPEUTICS INC reached its highest Cash to Assets over the past 5 years at 87.72%.
  • The lowest Cash to Assets recorded by PLUS THERAPEUTICS INC in the same timeframe 1.15%

PLUS THERAPEUTICS INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
OVID : OVID THERAPEUTICS INC 39.19%VERU : VERU INC 54.92%ALGS : ALIGOS THERAPEUTICS INC 13.93%CBUS : CIBUS INC 10.53%STTK : SHATTUCK LABS INC 78.4%DYAI : DYADIC INTERNATIONAL INC 48.84%CUE : CUE BIOPHARMA INC 72.72%MRKR : MARKER THERAPEUTICS INC 80%DTIL : PRECISION BIOSCIENCES INC 77.86%PYXS : PYXIS ONCOLOGY INC 9.91%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for PLUS THERAPEUTICS INC is calculated as follows: CashnEq [ $ 7.63M ] / Assets [ $ 11.65M ]
(=) Cash to Assets [ 65.44% ]

PSTV - Cash to Assets Ratio, Last 5 years

1.15%

Minimum

Dec 31, 2024

87.72%

Maximum

Sep 30, 2022

66.71%

Average

77.77%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.78% with a standard deviation of 9.53%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.76%
average9.78%
median6.42%
std9.53%